Toll Free: 1-888-928-9744

Cochlear Implants - Medical Devices Pipeline Assessment, 2016

Published: Apr 1, 2016 | Pages: 47 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Cochlear Implants - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Cochlear Implants - Medical Devices Pipeline Assessment, 2016" provides an overview of Cochlear Implants currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cochlear Implants pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cochlear Implants under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cochlear Implants and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cochlear Implants under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 5 2 Introduction 6 2.1 Cochlear Implants Overview 6 3 Products under Development 7 3.1 Cochlear Implants - Pipeline Products by Stage of Development 7 3.2 Cochlear Implants - Pipeline Products by Segment 8 3.3 Cochlear Implants - Pipeline Products by Territory 9 3.4 Cochlear Implants - Pipeline Products by Regulatory Path 10 3.5 Cochlear Implants - Pipeline Products by Estimated Approval Date 11 4 Cochlear Implants - Pipeline Products under Development by Companies 12 4.1 Cochlear Implants Companies - Pipeline Products by Stage of Development 12 4.2 Cochlear Implants - Pipeline Products by Stage of Development 13 5 Cochlear Implants Companies and Product Overview 14 5.1 Advanced Bionics, LLC Company Overview 14 5.1.1 Advanced Bionics, LLC Pipeline Products & Ongoing Clinical Trials Overview 14 5.2 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 16 5.2.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16 5.3 Hannover Medical School Company Overview 17 5.3.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 17 5.4 Labyrinth Devices Company Overview 18 5.4.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 18 5.5 Northwestern University Company Overview 19 5.5.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 19 5.6 Oticon Medical AB Company Overview 20 5.6.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 20 5.7 OtoKinetics Company Overview 21 5.7.1 OtoKinetics Pipeline Products & Ongoing Clinical Trials Overview 21 5.8 Sonova Holding AG Company Overview 23 5.8.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 23 5.9 Tel Aviv Sourasky Medical Center Company Overview 25 5.9.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 25 5.10 The University of Utah Company Overview 26 5.10.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 26 5.11 Trinity College Dublin Company Overview 28 5.11.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 28 5.12 University of Michigan Pediatric Device Consortium Company Overview 29 5.12.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 29 6 Cochlear Implants- Recent Developments 30 6.1 Nov 16, 2015: Advanced Bionics Launches the Naida CI Q90 Sound Processor in North America 30 6.2 Nov 16, 2015: First half results 2015/16: Solid performance in hearing instruments - held back by CI and FX 31 6.3 Oct 27, 2015: Parkinson's study patients reach 42 weeks post NTCELL implant 33 6.4 Oct 01, 2015: Cochlear Lifetime Commitment Continues for Recipients of First Commercially Available Cochlear Implant 33 6.5 Aug 18, 2015: AB announces FDA approval of Naida CI Q90 EAS, new sound processor 34 6.6 Aug 18, 2015: LCT planning to resume control of NTCELL manufacture 35 6.7 Aug 13, 2015: Overlake Medical Center is First in State to Use World's Thinnest Cochlear Implant 35 6.8 Jul 01, 2015: Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 36 6.9 Jun 24, 2015: FDA Approves Technology Upgrade for Recipients of First Commercially Available Cochlear Implant 36 6.10 Jun 14, 2015: NTCELL Clinical Study in Parkinson's Meets Endpoints 37 6.11 May 28, 2015: Advanced Bionics Announces TuV Approval of Naida CI Q90 EAS 38 6.12 May 26, 2015: Chris Smith Announced As Incoming Chief Executive Officer Of Cochlear 39 6.13 May 19, 2015: Sonova continues to deliver solid sales growth, margin expansion and strong cash flow performance 40 6.14 Apr 21, 2015: Cochlear: Judgment Entered In US Patent Infringement Case 42 6.15 Mar 25, 2015: Patient at UNC Hospitals is first in U.S. to receive newly approved cochlear implant 43 7 Appendix 44 7.1 Methodology 44 7.2 About GlobalData 46 7.3 Contact Us 47 7.4 Disclaimer 47
List of Tables
Table 1: Cochlear Implants - Pipeline Products by Stage of Development 7 Table 2: Cochlear Implants - Pipeline Products by Segment 8 Table 3: Cochlear Implants - Pipeline Products by Territory 9 Table 4: Cochlear Implants - Pipeline Products by Regulatory Path 10 Table 5: Cochlear Implants - Pipeline Products by Estimated Approval Date 11 Table 6: Cochlear Implants Companies - Pipeline Products by Stage of Development 12 Table 7: Cochlear Implants - Pipeline Products by Stage of Development 13 Table 8: Advanced Bionics, LLC Pipeline Products & Ongoing Clinical Trials Overview 14 Table 9: Hires Fidelity 120 Pediatrics - Product Status 15 Table 10: Hires Fidelity 120 Pediatrics - Product Description 15 Table 11: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16 Table 12: Cerashield Coated Cochlear Inner Ear Implant - Product Status 16 Table 13: Cerashield Coated Cochlear Inner Ear Implant - Product Description 16 Table 14: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 17 Table 15: Optical Cochlea Stimulator - Product Status 17 Table 16: Optical Cochlea Stimulator - Product Description 17 Table 17: Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 18 Table 18: Multi-Channel Vestibular Implant - Product Status 18 Table 19: Multi-Channel Vestibular Implant - Product Description 18 Table 20: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 19 Table 21: Cochlear Implant - Product Status 19 Table 22: Cochlear Implant - Product Description 19 Table 23: Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 20 Table 24: Neuro Cochlear Implant - Product Status 20 Table 25: Neuro Cochlear Implant - Product Description 20 Table 26: OtoKinetics Pipeline Products & Ongoing Clinical Trials Overview 21 Table 27: Krescendo I - Product Status 21 Table 28: Krescendo I - Product Description 21 Table 29: Krescendo II - Product Status 22 Table 30: Krescendo II - Product Description 22 Table 31: Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 23 Table 32: Next Generation Cochlear Implant - Product Status 24 Table 33: Next Generation Cochlear Implant - Product Description 24 Table 34: Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 25 Table 35: Implant Electrode Extender - Product Status 25 Table 36: Implant Electrode Extender - Product Description 25 Table 37: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 26 Table 38: Microphone Cochlear Implant - Product Status 27 Table 39: Microphone Cochlear Implant - Product Description 27 Table 40: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 28 Table 41: Closed-loop Cochlear Implant - Product Status 28 Table 42: Closed-loop Cochlear Implant - Product Description 28 Table 43: University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 29 Table 44: Enhanced Cochlear Implant Device - Product Status 29 Table 45: Enhanced Cochlear Implant Device - Product Description 29 Table 46: Glossary 45


List of Figures
Figure 1: Cochlear Implants - Pipeline Products by Stage of Development 7 Figure 2: Cochlear Implants - Pipeline Products by Segment 8 Figure 3: Cochlear Implants - Pipeline Products by Territory 9 Figure 4: Cochlear Implants - Pipeline Products by Regulatory Path 10 Figure 5: Cochlear Implants - Pipeline Products by Estimated Approval Date 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable gover

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify